Abiopharma

Syndax Announces Private Placement of $250.0 Million of Convertible Senior Notes

SU Group Awarded Next-Generation Cross-Border Security and High-Speed Vehicle Clearance System Installation

Ovid Therapeutics to Participate in Upcoming Investor Conferences

Fractyl Health Reports Positive One-Year REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® Procedure

AEON Biopharma to Present Data Demonstrating Structural and Functional Comparability of ABP-450 to BOTOX® at the 68th Annual Scientific Meeting of the American Headache Society

Ocular Therapeutix™ to Participate in Clinical Trials at the Summit 2026

Axsome Therapeutics Presents New SYMBRAVO® Data at the Americal Headache Society (AHS) 68th Annual Scientific Meeting

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Orion Reports FY 2026 Revenue of $86M and Adjusted EBITDA of $2.2M After Continued Growth in Q4; Reiterates FY 2027 Expectation of $95M-$97M in Revenue and Positive Adjusted EBITDA

GNP Seguros Announces Enterprise Expansion of Palantir Foundry and AIP Across All Lines of Business